You have read all your free articles, to continue reading subscribe to read the rest of this content.
The days are busy for Sweden’s Mikael Dolsten. As head of Pfizer’s R&D he is at the scientific forefront of the fight against the COVID-19 pandemic. Scientists and researchers across the globe are racing as never before to find treatments and a vaccine for the new coronavirus that has kilAlready…
The European Commission (EC) has granted Novavax conditional marketing authorization (CMA) for Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older. The authorization follows the European MedAlready a subscriber Login You have read all your free articles,…
The company’s qDBS dried blood spot system for home sample collection is being used in a nation-wide randomized clinical trial on the role of Vitamin D in COVID-19 run by Harvard Medical School. Participants in the study, who are recruited throughout the U.S., aged >18 years, and recently diAlready a…
NextCell Pharma has announced that a patent application has been filed for the treatment of Sars-CoV-2 mediated severe pneumonia with ProTrans. NextCell increases the IP protection for the drug candidate ProTrans for the treatment of autoimmune diseases and inflammatory conditions. The latest patAlready a subscriber Login You have read all…
